TAO SHEN to Lung Neoplasms
This is a "connection" page, showing publications TAO SHEN has written about Lung Neoplasms.
Connection Strength
1.147
-
Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation. Front Immunol. 2025; 16:1540578.
Score: 0.438
-
A Curcumin Derivative That Inhibits Vinyl Carbamate-Induced Lung Carcinogenesis via Activation of the Nrf2 Protective Response. Antioxid Redox Signal. 2015 Sep 10; 23(8):651-64.
Score: 0.223
-
Early Screening and Subtype Identification of High-Risk Lung Nodules via Breathprint by Graphene eNose Platform: A Large Cohort Study. ACS Sens. 2025 04 25; 10(4):3101-3111.
Score: 0.111
-
Multi-omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma. BMC Cancer. 2024 Sep 12; 24(1):1138.
Score: 0.106
-
Progress and challenges in RET-targeted cancer therapy. Front Med. 2023 Apr; 17(2):207-219.
Score: 0.097
-
Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma. Mol Cancer Ther. 2016 10; 15(10):2521-2529.
Score: 0.061
-
Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma. Br J Cancer. 2015 Dec 22; 113(12):1735-43.
Score: 0.058
-
Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells. Chem Biol Interact. 2020 Nov 01; 331:109279.
Score: 0.020
-
Drug resistance profiles of mutations in the RET kinase domain. Br J Pharmacol. 2018 09; 175(17):3504-3515.
Score: 0.017
-
A Versatile Tumor Gene Deletion System Reveals a Crucial Role for FGFR1 in Breast Cancer Metastasis. Neoplasia. 2017 May; 19(5):421-428.
Score: 0.016